0

  • Events
    • Event Details
Contemporary Issues in Urologic Pathology-2017
Location:
Doubletree By Hilton & Suites Charleston- Historic District
181 Church St Charleston, SC 29401-3122 
Date:
October 23-26, 2017
Add to Calendar Download

What’s New and Exciting for 2017

  • Use of 8th Edition of the AJCC/TNM Staging starts January, 2018
  • Release of new reporting standards by CAP and ICCR
  • Continued evolution of renal tumor classification
  • Most recent recommendations for prostate cancer reporting

 

General Information:

 

This course is designed for pathologists who want to enhance their skills in the diagnosis of urologic diseases. You will gain insights from expert faculty regarding the most important microscopic features for reaching an accurate diagnosis and utilizing ancillary techniques to best advantage. Challenging areas such as the diagnosis of prostatic adenocarcinoma on limited tissue, classifying kidney tumors and recognizing the many faces of urothelial carcinoma will be stressed.

 

You’ll gain insights into the 2016 WHO Classification of Urological Tumors and changes in the staging of urologic malignancies taking effect in January, 2018. You will hear about the evolving application of the Gleason grading system, reporting of prostate cancer containing specimens, gain confidence in diagnosing testicular germ cell tumors and learn about key issues in reporting bladder cancer specimens including an update on the role of urinary cytology. Throughout the course practical approaches to the handling, including gross examination and reporting of tumor specimens will be stressed.

 

Download PDF Order Form

  • List Price: $1,686.00 USD
  • Member Price: $1,296.00 USD
 
Want to save more?
to see if you qualify for a lower rate.
Members save $390.00 USD or more

Click here for course schedule

 

Credits:       24 CME Credits, 10 SAM CME Credit

 

Following this course, you will be able to:

 

  • Diagnose common and uncommon pathologic conditions involving the urologic organs
  • Select and interpret ancillary tests that...
View More View Less